News
Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Mar. 31, 2025. Recent Highlights. Q1 ...
RBC Capital lowered the firm’s price target on UnitedHealth (UNH) to $525 from $655 but keeps an Outperform rating on the shares. The firm is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback